Semaglutide , a prescription medication, steps in to lower blood sugar levels in adults with type 2 diabetes
For instance, CordenPharma's EURO 900 million investment announced in July 2024 to expand its peptide manufacturing platform highlights the increasing need for GLP-1 manufacturing capacity in the region
[1] [3] The medication works by mimicking the incretin hormone GLP-1, which stimulates insulin secretion in a glucose-dependent manner, suppresses glucagon release, slows gastric emptying, and reduces appetite through central nervous system pathways
After they take the money, however, they deliver something their clients didnt order fake drugs, perhaps, or just the disappointment that comes when people realize theyve been taken